Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1983 1
1984 2
1986 3
1987 1
1988 2
1989 5
1990 6
1991 3
1992 8
1993 6
1994 4
1995 2
1996 5
1997 8
1998 3
1999 7
2000 7
2001 5
2002 6
2003 2
2004 13
2005 9
2006 11
2007 13
2008 11
2009 18
2010 26
2011 18
2012 21
2013 32
2014 34
2015 39
2016 39
2017 48
2018 59
2019 54
2020 72
2021 69
2022 73
2023 76
2024 64
2025 76
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

859 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for matching ff
Search for Macchini FF instead (1 results)
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.
Stolz D, Hermansson E, Ouwens M, Singh B, Sharma A, Jackson D, Darken P, Marshall J, Bowen K, Müllerová H, Alcázar Navarrete B, Russell R, Han MK, Tansey-Dwyer D. Stolz D, et al. Curr Med Res Opin. 2023 Oct;39(10):1395-1405. doi: 10.1080/03007995.2023.2247969. Epub 2023 Aug 29. Curr Med Res Opin. 2023. PMID: 37583267 Free article.
We compared ACM in adults with moderate-to-very severe COPD receiving budesonide/glycopyrrolate/formoterol fumarate (BGF) in ETHOS versus fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) in IMPACT using a matching-adjusted indirect comparison (MAIC). METHODS …
We compared ACM in adults with moderate-to-very severe COPD receiving budesonide/glycopyrrolate/formoterol fumarate (BGF) in ETHOS versus fl …
The fusiform face area: a module in human extrastriate cortex specialized for face perception.
Kanwisher N, McDermott J, Chun MM. Kanwisher N, et al. J Neurosci. 1997 Jun 1;17(11):4302-11. doi: 10.1523/JNEUROSCI.17-11-04302.1997. J Neurosci. 1997. PMID: 9151747 Free PMC article.
In each of five subjects tested, the predefined candidate "face area" also responded significantly more strongly to passive viewing of (1) intact than scrambled two-tone faces, (2) full front-view face photos than front-view photos of houses, and (in a different set of five subje …
In each of five subjects tested, the predefined candidate "face area" also responded significantly more strongly to passive viewing of (1) i …
An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLL.
Kittai AS, Allan JN, James D, Bridge H, Miranda M, Yong ASM, Fam F, Roos J, Shetty V, Skarbnik A, Davids MS. Kittai AS, et al. Blood Adv. 2024 Jun 11;8(11):2861-2869. doi: 10.1182/bloodadvances.2023012142. Blood Adv. 2024. PMID: 38598745 Free PMC article.
The efficacy and safety of acalabrutinib plus obinutuzumab and acalabrutinib monotherapy vs zanubrutinib in patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma without del(17p) were compared using an unanchored matching-adjusted indirect c …
The efficacy and safety of acalabrutinib plus obinutuzumab and acalabrutinib monotherapy vs zanubrutinib in patients with treatment-naive ch …
The role of donor-recipient gender matching in lung transplantation: a systematic review.
Mangiameli G, Legras A, Arame A, Al Zreibi C, Mazzella A, LE Pimpec Barthes F. Mangiameli G, et al. Minerva Surg. 2022 Aug;77(4):391-398. doi: 10.23736/S2724-5691.22.09576-4. Epub 2022 May 16. Minerva Surg. 2022. PMID: 35575666
Sex matching is ignored and impact on outcome less investigated. EVIDENCE ACQUISITION: Systematic review of English literature using PubMed (1990-2019) was performed to evaluate the potential role of D-R matching in determining long-term outcome in patients after LT …
Sex matching is ignored and impact on outcome less investigated. EVIDENCE ACQUISITION: Systematic review of English literature using …
Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment-Naive Patients with COPD in the US.
Shaikh A, Ritz J, Casciano J, Palli SR, Clark B, Dotiwala Z, Quint JK. Shaikh A, et al. Int J Chron Obstruct Pulmon Dis. 2025 Feb 14;20:335-348. doi: 10.2147/COPD.S479504. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 39968202 Free PMC article.
PATIENTS AND METHODS: This retrospective study assessed administrative claims of maintenance treatment-naive patients in the United States with COPD aged 40 years initiating single-inhaler fluticasone furoate+umeclidinium+vilanterol (FF+UMEC+VI) or tiotropium+olodaterol (T …
PATIENTS AND METHODS: This retrospective study assessed administrative claims of maintenance treatment-naive patients in the United States w …
Diffusion time dependency of extracellular diffusion.
Xu J, Xie J, Semmineh NB, Devan SP, Jiang X, Gore JC. Xu J, et al. Magn Reson Med. 2023 Jun;89(6):2432-2440. doi: 10.1002/mrm.29594. Epub 2023 Feb 5. Magn Reson Med. 2023. PMID: 36740894 Free PMC article.
Dex was obtained over a broad t range (1-1000 ms) and then fit power-law equations Dex(t) = Dconst + const . t-t and Dex(f) = Dconst + const . ff . RESULTS: Both simulated and experimental results suggest that no single power-law adequately describes the behavior of Dex ov …
Dex was obtained over a broad t range (1-1000 ms) and then fit power-law equations Dex(t) = Dconst + const . t-t and Dex(f) = Dconst + const …
Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility.
Basyuni S, Heskin L, Degasperi A, Black D, Koh GCC, Chmelova L, Rinaldi G, Bell S, Grybowicz L, Elgar G, Memari Y, Robbe P, Kingsbury Z, Caldas C, Abraham J, Schuh A, Jones L; PARTNER Trial Group; Personalised Breast Cancer Program Group; Tischkowitz M, Brown MA, Davies HR, Nik-Zainal S. Basyuni S, et al. Nat Commun. 2024 Sep 4;15(1):7731. doi: 10.1038/s41467-024-51577-2. Nat Commun. 2024. PMID: 39231944 Free PMC article.
Despite inferior sequencing quality, FFPE-derived data identifies clinically-actionable variants, mutational signatures and permits algorithmic stratification. Matched FF/FFPE validation cohorts shows good concordance while acknowledging SBS, ID and copy-number arte …
Despite inferior sequencing quality, FFPE-derived data identifies clinically-actionable variants, mutational signatures and permits algorith …
Adaptive-modulated fast fluctuation super-resolution microscopy.
Liu Z, Yao L, Zhang L, Hou D, Fei Y, Mi L, Wang B, Ma J. Liu Z, et al. Opt Express. 2024 Nov 4;32(23):41173-41187. doi: 10.1364/OE.537728. Opt Express. 2024. PMID: 39573437 Free article.
Most cutting-edge SR methods require high-precision optical setups, which constrain the widespread adoption of SRM. Fluorescence fluctuation-based SRM (FF-SRM) can break the diffraction limit without complex optical components, making it particularly well-suited for biolog …
Most cutting-edge SR methods require high-precision optical setups, which constrain the widespread adoption of SRM. Fluorescence fluctuation …
Inhaled glucocorticoid-induced metabolome changes in asthma.
Daley-Yates P, Keppler B, Brealey N, Shabbir S, Singh D, Barnes N. Daley-Yates P, et al. Eur J Endocrinol. 2022 Jul 29;187(3):413-427. doi: 10.1530/EJE-21-0912. Print 2022 Sep 1. Eur J Endocrinol. 2022. PMID: 35900313 Free PMC article.

RESULTS: Quantifiable metabolites (1971) had few significant changes (% increases/decreases; P < 0.05) vs placebo: FF 1.34 (0.42/0.92), FP 1.95 (0.41/1.54) and BUD 2.05 (0.60/1.45). Therapeutic doses had fewer changes: FF 0.96 (0.36/0.61), FP 1.66 (0.44/1.22) and

…

RESULTS: Quantifiable metabolites (1971) had few significant changes (% increases/decreases; P < 0.05) vs placebo: FF 1.34 (0.42/0

…
[18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data.
Ballweg A, Klaus C, Vogler L, Katzdobler S, Wind K, Zatcepin A, Ziegler SI, Secgin B, Eckenweber F, Bohr B, Bernhardt A, Fietzek U, Rauchmann BS, Stoecklein S, Quach S, Beyer L, Scheifele M, Simmet M, Joseph E, Lindner S, Berg I, Koglin N, Mueller A, Stephens AW, Bartenstein P, Tonn JC, Albert NL, Kümpfel T, Kerschensteiner M, Perneczky R, Levin J, Paeger L, Herms J, Brendel M. Ballweg A, et al. J Neuroinflammation. 2023 Mar 11;20(1):68. doi: 10.1186/s12974-023-02749-2. J Neuroinflammation. 2023. PMID: 36906584 Free PMC article.
RESULTS: We selected the cerebellum as a pseudo-reference region based on the immunohistochemical comparison of age-matched PS2APP and WT mice. Subsequent PET imaging revealed that PS2APP mice showed elevated hippocampal and thalamic [(18)F]F-DED DVR when compared to age- …
RESULTS: We selected the cerebellum as a pseudo-reference region based on the immunohistochemical comparison of age-matched PS2APP an …
859 results